ReviewJournal of immunology research2026
From Defense to Disease: NADPH Oxidase in Cellular Function and Dysregulation.
Review in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) oxidase is an important family of enzymes that produce reactive oxygen species (ROS) and consists of NOX1-5, DUOX1, and DUOX2. These enzymes exhibit diverse tissue distributions with different activation mechanisms involved. They play vital roles in several physiological processes, such as defense against pathogens, wound healing, regulation of gene expression, post-translational modification of proteins, cell signaling, and cell differentiation. The present review highlights an indispensable role of NOX expression and resulting ROS production on various biological processes, specifically focusing on cell differentiation at various stages of embryonic development and differentiation of monocytes to macrophages within the mononuclear phagocytic system. It also discusses the influence of altered expression of NOX isoforms on the fate of macrophage polarization either towards pro-inflammatory (M1) or anti-inflammatory (M2) macrophages. Additionally, it discusses how the dysregulation of the cellular expression of NOXs is involved in the development and progression of a variety of chronic human diseases including cardiovascular diseases, cancer, diabetes, neurological diseases, and autoimmune disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.